Molecular basis of agonism and antagonism in the oestrogen receptor

Nature

Volumn 389, Issue 6652, 1997, Pages 753-758

  Brzozowski, Andrzej M ^a   Pike, Ashley C W ^a   Dauter, Zbigniew ^a   Hubbard, Roderick E ^a   Bonn, Tomas ^b   Engström, Owe ^b   Öhman, Lars ^b   Greene, Geoffrey L ^c   Gustafsson, Jan Åke ^d   Carlquist, Mats ^b  

^a UNIVERSITY OF YORK   (United Kingdom)

^b Karo Bio   (Sweden)

^c UNIVERSITY OF CHICAGO   (United States)

^d KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIESTROGEN; DRUG CARRIER; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; RALOXIFENE; TRANSCRIPTION FACTOR;

AGONIST; ARTICLE; CRYSTALLOGRAPHY; DRUG MECHANISM; DRUG RECEPTOR BINDING; ESTROGEN THERAPY; HORMONE RECEPTOR INTERACTION; LIGAND BINDING; PRIORITY JOURNAL; RECEPTOR BLOCKING; TRANSACTIVATION; TRANSCRIPTION REGULATION;

BINDING SITES; CRYSTALLOGRAPHY, X-RAY; ESTRADIOL; ESTROGEN ANTAGONISTS; HUMANS; MODELS, MOLECULAR; PIPERIDINES; PROTEIN CONFORMATION; RALOXIFENE; RECEPTORS, ESTROGEN;

EID: 0030667676     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/39645     Document Type: Article

References (29)

1. Ciocca, D. R. & Roig, L. M. V. Estrogen-receptors in human nontarget tissues - Biological and clinical implications. Endocr. Rev. 16, 35-62 (1995).
2. Tsai, M.-J. & O'Malley, B. W. Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu. Rev. Biochem. 63, 451-486 (1994).
3. Katzenellenbogen, J. A., O'Malley, B. W. & Katzenellenbogen, B. S. Tripartite steroid hormone receptor pharmacology: Interaction with multiple effector sites as a basis for the cell- and promoter-specific action of these hormones. Mol. Endocrinol. 10, 119-131 (1996).
4. Beato, M. & Sánchez-Pacheco, A. Interaction of steroid hormone receptors with the transcription initiation complex. Endocr. Rev. 17, 587-609 (1996).
5. Grese, T. A. et al. Structure-activity relationships of selective estrogen receptor modulators: Modifications to the 2-arylbenzothiophene core of raloxifene. J. Med. Chem. 40, 146-167 (1997).
6. Wagner, R. L. et al. A structural role for hormone in the thyroid hormone receptor. Nature 378, 690-697 (1995).
7. Renaud, J.-P. et al. Crystal structure of the RAR-γ ligand-binding domain bound to all-trans retinoic acid. Nature 378, 681-689 (1995).
8. Bourguet, W., Ruff, M., Chambon, P., Gronemeyer, H. & Moras, D. Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-α. Nature 375, 377-382 (1995).
9. Wurtz, J.-M. et al. A canonical structure for the ligand-binding domain of nuclear receptors. Nature Struct. Biol. 3, 87-94 (1996).
10. Kumar, V. & Chambon, P. The estrogen receptor binds tightly to its responsive element as a ligand-induced homodimer. Cell 55, 145-156 (1988).
11. Fawell, S. E., Lees, J. A., White, R. & Parker, M. G. Characterisation and colocalization of steroid binding and dimerization activities in the mouse estrogen receptor Cell 60, 953-962 (1990).
12. Anstead, G. M., Carlson, K. E. & Katzenellenbogen, J. A. The estradiol pharmacophore: Ligand structure-estrogen receptor binding affinity relationships and a model for the receptor binding site. Steroids 62, 268-303 (1997).
13. Katzellenbogen, B. S. et al. Antiestrogens: Mechanisms and actions in target cells. J. Steroid Biochem. Mol. Biol. 53, 387-393 (1995).
14. Draper, M. W. et al. A controlled trial of raloxifene (LY139481) HCl: Impact on bone turnover and serum lipid profile in healthy postmenopausal women. J. Bone Miner. Res. 11, 835-842 (1996).
15. Ekena, K., Weis, K. E., Katzenellenbogen, J. A. & Katzenellenbogen, B. S. Different residues of the human estrogen receptor are involved in the recognition of structurally diverse estrogens and antiestrogens. J. Biol. Chem. 272, 5069-5075 (1997).
16. Cavaillès, V., Dauvois, S., Danielian, P. S. & Parker, M. G. Interaction of proteins with transcriptionally active estrogen receptors. Proc. Natl Acad. Sci. USA 91, 10009-10013 (1994).
17. L'Horset, F., Dauvois, S., Heery, D. M., Cavaillès, V. & Parker, M. G. RIP-140 interacts with multiple nuclear receptors by means of two distinct sites. Mol. Cell. Biol. 16, 6029-6036 (1996).
18. vom Baur, E. et al. Differential ligand-dependent interactions between the AF-2 activating domain of nuclear receptors and the putative transcriptional intermediary factors mSUG1 and TIF1. EMBO J. 15, 110-124 (1996).
19. Danielian, P. S., White, R., Lees, J. A. & Parker, M. G. Identification of a conserved region required for hormone dependent transcriptional activation by steroid hormone receptors. EMBO J. 11, 1025-1033 (1992).
20. Pakdel, F., Reese, J. C. & Katzenellenbogen, B. S. Identification of charged residues in an N-terminal portion of the hormone-binding domain of the human estrogen receptor important in transcriptional activity of the receptor. Mol. Endocrinol. 7, 1408-1417 (1993).
21. Henttu, P. M. A., Kalkhoven, E. & Parker, M. G. AF-2 activity and recruitment of steroid receptor coactivator 1 to the estrogen receptor depend on a lysine residue conserved in nuclear receptors. Mol. Cell. Biol. 17, 1832-1839 (1997).
22. McInerney, E. M. & Katzenellenbogen, B. S. Different regions in activation function-1 of the human estrogen receptor required for antiestrogen- and estradiol-dependent transcriptional activation. J. Biol. Chem. 271, 24172-24178 (1996).
23. McInerney, E. M., Tsai, M.-J., O'Malley, B. W. & Katzenellenbogen, B. S. Analysis of estrogen receptor transcriptional enhancement by a nuclear hormone receptor coactivator. Proc. Natl Acad. Sci. USA 93, 10069-10073 (1996).
24. Hegy, G. B. et al. Carboxymethylation of the human estrogen receptor ligand-binding domain- estradiol complex: HPLC/ESMS peptide mapping shows that cysteine 447 does not react with iodoacetic acid. Steroids 61, 367-373 (1996).
25. Otwinowski, Z. & Minor, W. Processing X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276, 307-326 (1997).
26. Collaborative Computational Project No. 4. The CCP4 suite: programs for protein crystallography. Acta Crystallogr. D 50, 760-763 (1994).
27. Murshudov, G. N., Vagin, A. A. & Dodson, E. J. Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr. D 53, 240-255 (1997).
28. Wallace, A. C., Laskowski, R. A. & Thornton, J. M. LIGPLOT - A program to generate schematic diagrams of protein ligand interactions. Prot. Eng. 8, 127-134 (1995).
29. Laskowski, R. A., MacArthur, M. W., Moss, D. S. & Thornton, J. M. PROCHECK: a programme to check the stereochemical quality of protein structure coordinates. J. Appl. Crystallogr. A 42, 140-149 (1993).